SWKS
38
-2
DOV
64
-5
KEY
51
-3
TDC
59
10
ALL
61
-2
IR
72
-5
ADI
59
-2
ADM
33
-3
FAST
46
-3
HCP
64
-2
MMC
58
-2
PNC
57
-2
AN
50
-5
FOXA
48
7
NRG
69
12
NEM
48
2
GOOG
67
2
R
66
-4
MSI
72
2
DUK
64
2
SWKS
38
-2
DOV
64
-5
KEY
51
-3
TDC
59
10
ALL
61
-2
IR
72
-5
ADI
59
-2
ADM
33
-3
FAST
46
-3
HCP
64
-2
MMC
58
-2
PNC
57
-2
AN
50
-5
FOXA
48
7
NRG
69
12
NEM
48
2
GOOG
67
2
R
66
-4
MSI
72
2
DUK
64
2
Financhill
Back

Ultralife Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

ULBI
Ultralife

Last Price:
9.28
Seasonality Move:
-2.51%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Ultralife (ULBI) is a Sell

Is Ultralife a Buy, Sell or Hold?

  • The current Ultralife [ULBI] share price is $9.27. The Score for ULBI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ULBI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ULBI Stock Price Chart

What is Ultralife's stock price today?

  • The Ultralife share price today is $9.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ULBI is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ULBI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 39.43 Sell
Chaikin Money Flow: -34729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.34 - 10.56) Sell
Bollinger Bands (100): (9.88 - 11.72) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ULBI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.43 Sell
20-day SMA: 9.83 Sell
50-day SMA: 10.41 Sell
200-day SMA: 9.49 Sell
8-day EMA: 9.45 Sell
20-day EMA: 9.72 Sell
50-day EMA: 10.13 Sell
200-day EMA: 9.63 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Ultralife Earnings Growth & ULBI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $0.31 per share, and an increase next year of $0.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Ultralife Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):